Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Medications for benign prostatic syndrome can cause cognitive issues and depression.

A new method was developed to accurately measure enzyme activity related to prostate health.

Baldness score can't be used to predict prostate size.

Men with urinary issues often don't stick to their medication long-term.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Finasteride and dutasteride can affect sexual function in BPH patients.

Finasteride may help treat BPH by affecting certain biological markers.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.

Provenge extends prostate cancer survival by about 4 months.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Scutellaria baicalensis may help treat benign prostatic hyperplasia.

Men with enlarged prostates often have more severe baldness.

Tamsulosin hydrochloride is safe and effective for long-term treatment of urinary symptoms in BPH patients.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.